See more : Embracer Group AB (publ) (0GFE.L) Income Statement Analysis – Financial Results
Complete financial analysis of Intelligent Medicine Acquisition Corp. (IQMD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Intelligent Medicine Acquisition Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- Cardio Diagnostics Holdings, Inc. (CDIO) Income Statement Analysis – Financial Results
- Cornerstone Strategic Value Fund, Inc. (CLM) Income Statement Analysis – Financial Results
- Leejam Sports Company (1830.SR) Income Statement Analysis – Financial Results
- Theralink Technologies, Inc. (THER) Income Statement Analysis – Financial Results
- Beyond International Limited (BYI.AX) Income Statement Analysis – Financial Results
Intelligent Medicine Acquisition Corp. (IQMD)
Industry: Shell Companies
Sector: Financial Services
About Intelligent Medicine Acquisition Corp.
Intelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science. The company was incorporated in 2021 and is based in Bethesda, Maryland.
| Metric | 2022 | 2021 |
|---|---|---|
| Revenue | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 |
| General & Administrative | 1.28M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 |
| SG&A | 1.28M | 0.00 |
| Other Expenses | 0.00 | 0.00 |
| Operating Expenses | 1.28M | 0.00 |
| Cost & Expenses | 1.28M | 0.00 |
| Interest Income | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 |
| Depreciation & Amortization | 0.00 | 236.56K |
| EBITDA | -14.54M | 0.00 |
| EBITDA Ratio | 0.00% | 0.00% |
| Operating Income | -14.77M | 0.00 |
| Operating Income Ratio | 0.00% | 0.00% |
| Total Other Income/Expenses | 26.74M | 0.00 |
| Income Before Tax | 11.97M | 0.00 |
| Income Before Tax Ratio | 0.00% | 0.00% |
| Income Tax Expense | 562.57K | 0.00 |
| Net Income | 11.41M | 0.00 |
| Net Income Ratio | 0.00% | 0.00% |
| EPS | 2.20 | 0.00 |
| EPS Diluted | 2.20 | 0.00 |
| Weighted Avg Shares Out | 5.18M | 25.88M |
| Weighted Avg Shares Out (Dil) | 5.18M | 25.88M |
Intelligent Medicine Acquisition Corp. Announces It Will Redeem Its Public Shares
Intelligent Medicine Acquisition Corp. Announces Adjournment of Special Meeting of Stockholders
Source: https://incomestatements.info
Category: Stock Reports